Immune system augmentation via humanization using stem/progenitor cells and bioengineering in a breast cancer model...

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cancer Biology

Background:

• Current in vivo models inadequately replicate human biological processes.
• There is a need for advanced humanized models that mimic human organ systems.
• Understanding cancer-bone interactions requires sophisticated in vivo systems.

Purpose of the Study:

• To develop an advanced humanized bone model.
• To create a functional organ bone with diverse cellular components.
• To investigate breast cancer metastasis in a humanized microenvironment.

Main Methods:

• Human mesenchymal stem/stromal cells (MSCs), endothelial cells, and preosteoblasts were cultured within engineered scaffolds.
• Tissue-engineered bone (TEB) was implanted in mice and further humanized with CD34+ cells.
• Metastatic breast cancer cells were orthotopically injected to study tumor formation and metastasis.

Main Results:

• The engineered bone (hTEB) formed a functional organ bone in vivo.
• Humanized mice showed primary tumor formation and metastasis to the hTEB and other organs.
• Reduced metastasis and tumor burden in hematochimeric mice suggested an immune response.

Conclusions:

• Tissue engineering effectively creates humanized bone models for studying cancer-bone interactions.
• The developed model allows for investigation of species-specific cancer metastasis.
• Future research can explore genetically modified cells and advanced microenvironments for deeper insights.